EMA is committed to support patients living with a rare disease.

The orphan medicines programme for #rarediseases has helped to stimulate the development of new treatments. In over 20 years more than 2⃣3⃣0⃣ have been authorised in the 🇪🇺.

Find out more➡️ https://www.ema.europa.eu/en/human-regulatory/overview/orphan-designation-overview#rare-diseases-at-a-glance-section

🐦🔗: https://n.respublicae.eu/EMA_News/status/1630614446690254862